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Abstract DNA methylation is intricately involved in a variety
of cellular processes, such as differentiation, cell cycle progres-
sion, X-chromosome inactivation and genomic imprinting.
However, little is known about how specific DNA methylation
patterns are established and maintained. Previously one mam-
malian DNA methyltransferase has been described, but there has
been considerable speculation about the presence of a second
activity capable of methylation. Here we report the identification
and characterization of a novel human putative DNA methyl-
transferase. Using a bioinformatics screen we have identified
several expressed sequence tags which show high sequence
similarity to the Schizosaccharomyces pombe gene pmt1+. The
cDNA for PuMet (for putative DNA methyltransferase) was
cloned and the predicted amino acid sequence deduced. The gene
is ubiquitously expressed, albeit at low levels. Like several other
DNA methyltransferases, the bacterially overexpressed protein is
not active in methylation assays.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Methylation at position 5 of the cytosine ring in the dinu-
cleotide CpG is the major modi¢cation of DNA in higher
eukaryotes. DNA methylation correlates with silencing of
gene expression [1,2] and it was proposed as a mechanism
to reduce transcriptional noise [3] and to suppress the activa-
tion of parasitic DNA sequences [4]. Methylation patterns are
inherited from one cell generation to the next by the postre-
plicative action of the DNA methyltransferase (DNMT) [5].
DNMT recognizes hemimethylated DNA and adds a methyl
group to the newly synthesized daughter strand, thus main-
taining the methylation pattern of the parental DNA [6].
However, at least in early development, methylation patterns
are much more dynamic. After fertilization, the DNA in the
blastocyst undergoes almost complete demethylation, which is
followed by a wave of global de novo methylation [7]. During
the subsequent implantation of the embryo and di¡erentiation
of the somatic cells, genes receive their tissue-speci¢c methyl-
ation pattern [8]. Thus, subsequent phases of demethylation,
de novo methylation and maintenance methylation are re-
quired to establish the methylation pattern of DNA in so-
matic cells.
So far, the only known mammalian DNA methyltransferase
is DNMT [9,10]. DNMT has a long N-terminal domain which
targets the enzyme to the nucleus and to replication foci [11].
The C-terminus contains the catalytic domain, which is clearly
homologous to bacterial DNA methyltransferases. The in vi-
tro preference of the enzyme for hemimethylated DNA is
consistent with its role in maintenance methylation [5]. Em-
bryonic stem (ES) cells carrying a null mutation of the dnmt
gene contain no maintenance methylation activity, but retain
the ability to methylate integrated provirus DNA de novo,
suggesting the presence of at least one additional DNA meth-
yltransferase in mammalian cells [12,13].
This report describes the identi¢cation and analysis of a
novel human putative DNA methyltransferase. Using a bio-
informatics screen several overlapping expressed sequence tags
(ESTs) were identi¢ed which show high similarity to all bac-
terial and eukaryotic DNA methyltransferases. Interestingly,
the highest similarity is to the PMT1 protein, a ‘pseudo DNA
methyltransferase’ identi¢ed in Schizosaccharomyces pombe
[14,15]. The putative methyltransferase (PuMet) is expressed
at very low levels in a variety of human tissues. The PuMet
gene is located on chromosome 10p13^22. However, bacteri-
ally overexpressed protein does not show any methyltransfer-
ase activity in vitro.
2. Materials and methods
2.1. Bioinformatics strategy for the identi¢cation of DNA
methyltransferase ESTs from databases
A multiple sequence alignment was generated using the protein
sequences from human, mouse, and Arabidopsis DNA methyltransfer-
ases together with the sequence of the prokaryotic CpG methyltrans-
ferase from Spiroplasma sp. The SwissProt database identi¢ers are
MTDM_HUMAN, MTDM_MOUSE, MTDM_ARATH and
MTSI_SPISQ, respectively. Based on the multiple sequence alignment
a similarity pro¢le was calculated and applied to subsequent Pro¢le-
searches [16] in the SwissProt release 35 protein database [17]. Positive
hits were used to optimize and re¢ne the multiple alignment before
searching in DNA databases. The similarity pro¢le contained amino
acids 1020^1220 with respect to human DNMT (see Fig. 1C). The
EMBL DNA database release 52 [18] was probed with the proframe-
search program. Searches were performed on a dedicated hardware
accelerator (Bioccelerator, Compugen, Israel). All human ESTs ob-
tained by the similarity search were subjected to reverse screening of
the protein database with Framesearch and BlastX similarity search
programs.
2.2. Cloning and overexpression of PuMet
Clones containing ESTs encoding the putative DNA methyltrans-
ferase were obtained from the Image consortium (clones 663573,
198982 and 266751). DNA sequencing was carried out on double-
stranded plasmid DNA with dye-terminator chemistry as described
by the manufacturer (Perkin Elmer/Applied Biosystems) and the prod-
ucts were resolved on an ABI Prism 377 Automated Sequencer. The
EMBL/GenBank accession number for the PuMet sequence is
AJ223333. Two primers (forward: 5P-AGG AGC TCG GCG CGG
GGA TGG AGC CC-3P ; reverse: 5P-GGC CAT GGC AGA ATT
ACT CTC TGA AAA TG-3P), containing a SacI and a NcoI restric-
tion site respectively, were designed based on the EST 663573 se-
quence, which contains the full PuMet coding region. PCR reactions
were performed using the EST 663573 plasmid and the resulting 1261
bp fragment was cloned into the expression vector pRSET (Invitro-
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Fig. 1. A: Alignment of EST clones identi¢ed in a bioinformatics screen for novel human DNA methyltransferases. Clone numbers and clone
lengths in bp are indicated. The position of the open reading frame (ORF) of PuMet is indicated by the dark arrow. B: cDNA sequence and
deduced amino acid sequence of PuMet. GenBank accession number is AJ223333. C: Alignment of the amino acid sequence of PuMet, pmt1
(accession number X82444) and the human DNA methyltransferase (DNMT, accession number X63692). Amino acid sequences were aligned
using the Clustal W multiple sequence algorithm and conserved amino acid residues were annotated using the GeneDoc program. The 10 con-
served motifs found in 5-methylcytosine methyltransferases are indicated according to Wilkinson et al. [14].
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gen). Overexpression was in Escherichia coli BL21(DE3) (Novagen).
100 ml of 2UYT medium containing 50 mg/ml ampicillin was inocu-
lated with 1 ml overnight culture and incubated at 37‡C with vigorous
shaking. Optimal induction for maximum expression of soluble pro-
tein was found at OD600=0.5. Overexpression was induced by addition
of IPTG to 1 mM and cells were further incubated at 30‡C for 2 h.
Cells were collected by centrifugation (4000Ug, 15 min, 4‡C) and the
pellet resuspended in lysis bu¡er (50 mM NaH2PO4, pH 8.0; 300 mM
NaCl; 10 mM imidazole) at 2^5 ml per gram wet weight. Lysozyme
was added to 1 mg/ml and after a 30 min incubation on ice the
suspension was sonicated using ten 10 s bursts with a 10 s cooling
period between bursts. The lysate was cleared by centrifugation
(10 000Ug, 30 min, 4‡C) and the protein puri¢ed from the superna-
tant. 1 ml of 50% (w/v) Ni-NTA silica (Qiagen) was added to 4 ml of
the supernatant. The slurry was mixed gently at 4‡C for 60 min and
loaded onto a column. The column was washed two times with 4 ml
wash bu¡er (50 mM NaH2PO4, pH 8.0; 300 mM NaCl; 20 mM
imidazole) and protein eluted with 4U0.5 ml elution bu¡er (50 mM
NaH2PO4, pH 8.0; 300 mM NaCl; 250 mM imidazole). All fractions
were collected and analyzed by SDS-PAGE. Pooled fractions of Pu-
Met protein were dialyzed overnight against 2 l PBS. Control lysates
from bacteria grown with an insert-less pRSET vector were prepared
in the same way.
2.3. Methylation assay
The activity of the puri¢ed PuMet protein was measured using S-
adenosyl-L-[methyl-3H]methionine (3H-SAM) as methyl group donor.
DNA substrates were either plasmid DNA or poly d[d(I-C) d(I-C)]
(Sigma, 13 units/mg). 5 Wg DNA was methylated in a 50 Wl reaction in
NEBu¡er 2 (New England Biolabs) containing 64 WM 3H-SAM
(Amersham, 79 Ci/mmol) and 13.75 Wg of the puri¢ed PuMet protein
for 2 h at 37‡C. The reaction was stopped by adding an equal volume
of stop mix containing 2% SDS, 10 mM EDTA and 1 mg/ml protein-
ase K followed by a 30 min incubation at 55‡C. To each sample 40 Wl
1.05 M NaOH was added and the samples were incubated at 60‡C
for 10 min. Samples were transferred to a 96 well GF/C Millipore
¢ltration plate. 20 Wl salmon sperm DNA (Promega, 1 mg/ml) was
added and the DNA precipitated with 80 Wl 30% trichloroacetic acid
(TCA), 15 mM sodium pyrophosphate. Tritiated SAM was removed
by washing the wells 10 times with 200 Wl 5% TCA, 5 mM sodium
pyrophosphate and twice with ethanol. After drying, 50 Wl Microscin-
tO (Packard) was added and samples were counted in a Packard
microplate scintillation counter. The negative control contained equiv-
alent amounts of bovine serum albumin (BSA) instead of puri¢ed
protein, the positive control contained DNA methyltransferase SssI
(New England Biolabs). In addition, extracts from bacteria grown
with a vector containing no PuMet insert were assayed in the same
way as described above.
2.4. Expression analysis of PuMet
Two human multiple tissue Northern (MTN) blots, a cancer cell
line and a human endocrine system multiple tissue Northern blot (all
from Clontech and containing 2 Wg poly(A) RNA per lane) were
probed with a 1093 bp NspI fragment corresponding to the PuMet
ORF, labeled with 32P-dCTP by random priming using the rediprime
DNA labeling system (Amersham). The blots were washed at high
stringency (2U20 min with 0.1USSC, 0.1% SDS, 65‡C) and exposed
at 370‡C to Kodak Bio Max autoradiography ¢lm with intensifying
screens. The blots were then rehybridized without stripping as de-
scribed above with a random primed 3890 bp ApaI fragment from
the human DNMT cDNA. Blots were stripped with boiling SDS
solution (0.5%) for 10 min and rehybridized with a L-actin probe
(Clontech) as described.
Variations in the subsequent hybridization of the Northern blots
were kept at a minimum in order to allow an approximate comparison
of expression signals. The same amount of probe (30 ng) was used in
the labeling reactions which resulted in closely matched speci¢c activ-
ities for the three di¡erent probes (5U108 dpm/Wg). Hybridization and
washing conditions were kept identical for all three probes. The
Northern blots were exposed for 16 h to a phosphoimager screen
and hybridization signals were quanti¢ed using a Storm phospho-
imaging system (Molecular Dynamics).
2.5. Fluorescence in situ hybridization studies (FISH)
Chromosomal localization was carried out by SeeDNA Inc. (On-
tario, Canada). Lymphocytes isolated from human blood were cul-
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tured in K-minimal essential medium (K-MEM) supplemented with
10% fetal calf serum and phytohemagglutinin at 37‡C for 68^72 h.
The lymphocyte cultures were treated with bromodeoxyuridine (0.18
mg/ml) to synchronize the cell population. The synchronized cells
were washed three times with serum-free medium to release the bro-
modeoxyuridine block and recultured at 37‡C for 6 h in K-MEM with
thymidine (2.5 mg/ml). Cells were harvested and slides were prepared
by using standard procedures including hypotonic treatment, ¢xation
and air-drying.
A PuMet cDNA fragment was gel-puri¢ed and biotinylated with
dATP using the BRL BioNick labeling kit (15‡C, 1 h) [19]. The pro-
cedure for FISH detection was performed as previously described
[19,20]. Brie£y, slides were baked at 55‡C for 1 h. After RNase treat-
ment, the slides were denatured in 70% formamide in 2USSC for
2 min at 70‡C followed by dehydration with ethanol. Probes were
denatured at 75‡C for 5 min in a hybridization mix consisting of
50% formamide and 10% dextran sulfate. Probes were loaded on
the denatured chromosomal slides. After overnight hybridization,
slides were washed and the signal detected. FISH signals and the
4P,6-diamidino-2-phenylindole (DAPI) banding pattern were recorded
separately by taking photographs, and the assignment of the FISH
mapping data to chromosomal bands was achieved by superimposing
FISH signals with DAPI-banded chromosomes [21].
3. Results and discussion
3.1. Cloning and sequence analysis of PuMet
Using the mouse, human, Arabidopsis and SssI DNA meth-
yltransferase protein sequences, a 200 amino acid pro¢le was
created which contained the active site and motifs I^VIII (Fig.
1C) of the known DNA methyltransferases. This pro¢le was
then used as a probe to screen human EST databases. Several
hits were identi¢ed, most of which were ESTs from the known
DNA methyltransferase gene, DNMT [9,10]. However, some
of the identi¢ed sequences were distinctly di¡erent from the
DNMT gene, but instead were more similar to the pmt1 gene
from S. pombe [14]. The pmt1 gene from S. pombe encodes a
protein clearly homologous to prokaryotic and eukaryotic
DNA methyltransferases. However, this protein does not
show any signi¢cant methyltransferase activity in vitro, which
is consistent with the lack of any detectable 5-methylcytosine
in S. pombe DNA [14].
The identi¢ed ESTs formed one contig encoding a protein
which we named PuMet (for putative methyltransferase). Fig.
1A shows a map of the position of the EST clones and Fig. 1B
shows the cDNA sequence with the deduced amino acid se-
quence. The cDNA contains an open reading frame of 391
amino acids and has a long 3P untranslated region of 2.3 kb.
Several 5P RACE reactions did not yield clones which extend
the sequence beyond that of EST 663573, suggesting that
clone 663573 contains the full 5P untranslated region of the
PuMet cDNA. Comparison of the predicted amino acid se-
quence of PuMet with both prokaryotic and eukaryotic 5-
methylcytosine methyltransferases (5mC-MTases) reveals a
high degree of similarity (Fig. 1C). The predicted molecular
mass of 45 kDa is within the range found for known bacterial
5mC-MTases. This is in contrast to the known mammalian
5mC-MTases which have an additional N-terminal domain of
approximately 1000 amino acids long, which is involved in
nuclear localization and targeting of the enzyme to replication
foci [11] and is also a target for the cell cycle machinery [22].
The C-terminal domain of the mammalian enzymes contains
the catalytic domain, and is similar to the bacterial enzymes.
Ten conserved motifs have previously been identi¢ed in this
domain, which are also found in the amino acid sequence of
PuMet, with strongest conservation in motifs I, IV, VI and IX
(see Fig. 1C). The active site, a PPCQ tetrapeptide in motif
IV, is perfectly conserved between the human DNMT and
PuMet. However, in the S. pombe pmt1 sequence a PSCQ
motif is present and it was concluded that this may cause
catalytic inactivity of the pmt1 protein [14]. Subsequently,
Pinarbasi et al. [15] deleted the serine residue in the pmt1
protein, which restored the Pro-Cys motif, and as a conse-
quence also restored methyltransferase activity of the protein.
FEBS 20129 17-4-98
Fig. 2. Chromosomal localization of the PuMet gene determined by FISH analysis. A: Photograph of metaphase chromosome spread labeled
with £uorescent PuMet cDNA probe. B: Photograph of the same mitotic ¢gure stained with DAPI to identify chromosomes and reveal chro-
mosome band patterns. Comparison with A shows the FISH signal is located on chromosome 10. C: Idiogram of chromosome 10. The signal
was further localized to position p13^22 by determination of the distribution of signals from 10 independent photographs.
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3.2. Chromosomal localization of the PuMet gene
The chromosomal position of the PuMet gene was deter-
mined to establish whether loss of heterozygosity (LOH) as-
sociated with PuMet might be linked with any known disease.
The insert of EST clone 663573 was used as a probe for FISH
mapping. Under the conditions used, the hybridization e⁄-
ciency was approximately 71% for the probe (among 100
checked mitotic ¢gures, 71 showed signals on one pair of
chromosomes). The DAPI banding pattern was used to estab-
lish that the PuMet gene localizes to the short arm of chro-
mosome 10. The detailed position was further determined
based upon the analysis of 10 photographs leading to the
conclusion that the PuMet gene is located on human chromo-
some 10, region p13^22 (Fig. 2). However, queries of the
Genome Data Base (Johns Hopkins University) for this re-
gion did not result in any signi¢cant markers which may be
relevant to a certain disease.
3.3. Overexpression of PuMet
The coding region of the PuMet gene was cloned into the
bacterial expression vector pRSET-A which resulted in the
addition of an N-terminal 6UHis tag to the recombinant
protein. Previously, this has not led to an impairment of
DNA methylation activity for prokaryotic and eukaryotic
DNA methyltransferases [23]. Subsequently the overexpressed
protein was puri¢ed by Ni-NTA chromatography (Fig. 3A).
Puri¢ed fractions were used in methylase assays according to
Adams et al. [24]. As shown in Fig. 3B, the puri¢ed protein
did not show any methyltransferase activity compared to the
positive control methyltransferase SssI, using poly(dIdC) and
plasmid DNA (Fig. 3B) or lambda and calf thymus DNA
(data not shown) as DNA substrates. In addition, the PuMet
cDNA was cloned into the mammalian expression vector
pcDNA3 (Pharmacia). However, COS cells did not show ele-
vated levels of DNA methyltransferase activity upon transient
FEBS 20129 17-4-98
Fig. 3. A: Puri¢cation of bacterially overexpressed PuMet protein. SDS-PAGE of fractions from a typical protein puri¢cation. Lane 1: protein
extract from bacteria grown with an insert-less vector control; lane 2: protein extract from uninduced PuMet-expressing bacteria; lane 3: pro-
tein extract from induced (2 h) PuMet-expressing bacteria; lanes 4 and 5: insoluble and soluble fraction of protein extract from induced Pu-
Met-expressing bacteria; lane 6: Ni-NTA-puri¢ed PuMet; lane 7: equivalent of one unit of methylase SssI (New England Biolabs). Size
markers are indicated. B: Methylation assay of fractions obtained during puri¢cation of bacterially overexpressed PuMet; methylase SssI (New
England Biolabs) was included as a positive control and is a CpG-speci¢c 5-methylcytosine methyltransferase. Hatched and ¢lled bars represent
duplicate samples of the same experiment. FT: £ow-through. BSA indicates the use of an equivalent amount of BSA in the methylation reac-
tion as a negative control.
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transfection with these constructs (data not shown). We con-
clude that, under our assay conditions, PuMet has no DNA
methyltransferase activity. A recently identi¢ed DNA methyl-
transferase from Ascobolus was similarly overexpressed and
was also inactive using these heterologous expression systems
[25]. Conceivably, an additional protein or cofactor may be
required for the activity of these types of eukaryotic DNA
methyltransferases, because they lack the large N-terminal
domain present in DNMT. However, the protein may also
lack any DNA methyltransferase activity. In a recent study,
Yoder et al. [26] used a mechanism-based probe to detect de
novo methyltransferases in lysates from ES cells and from
cells derived from di¡erent developmental stages of mouse
embryos. They concluded that the predominant de novo
methyltransferase activity in those tissues which are known
to be active in de novo methylation is DNMT. Thus,
DNMT but not PuMet may actually be responsible for de
novo methyltransferase activity during early development.
However, it cannot be excluded that an as yet unidenti¢ed
protein is responsible for de novo methylation in mammalian
systems.
3.4. Tissue-speci¢c expression of the PuMet gene
In order to establish the expression pro¢le of PuMet a series
of Northern hybridization experiments was carried out. Three
mRNA species of approximately 8, 4 and 1.8 kb are detected
on Northern blots containing poly(A) mRNA (Fig. 4).
Whereas the band of approximately 4 kb probably corre-
sponds to the identi¢ed PuMet cDNA, the nature of the larger
and smaller mRNA is unknown. Overall, the gene for PuMet
is expressed in most tissues analyzed; however, expression
levels are very low. Expression appears to be slightly elevated
in thymus, thyroid and testis (Fig. 4B, lanes 2 and 4 and Fig.
4D, lanes 3 and 5). Highest expression is seen in three cancer
cell lines (Fig. 4C, lanes 2^4). The same blots were also hy-
bridized to a probe derived from the human DNMT gene.
Hybridization signals were compared using phosphoimaging
analysis (see Section 2). Interestingly, expression of the
DNMT gene is about 20^30-fold higher compared to PuMet,
with highest expression in placenta (Fig. 4A), thymus and
testis (Fig. 4B,D). Importantly, DNMT appears to be overex-
pressed in all cancer lines analyzed (Fig. 4C), which is con-
sistent with the role of DNA methylation in the onset and
progression of cancer [27]. Based on the low levels of expres-
sion of PuMet in the various tissues it is di⁄cult to predict a
distinct role for PuMet. Considering the approximately 20^30-
fold higher expression levels of DNMT and the recent evi-
dence for its involvement in de novo methylation of DNA
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Fig. 4. Northern blot analysis of PuMet and DNMT. Multiple tissue Northern blots were hybridized as described in Section 2. The RNA
source is indicated above the lanes. Exposure time of X-ray ¢lm was 80 h for PuMet, 5 h for DNMT and 4 h for L-actin, respectively. See Sec-
tion 2 for details.
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[26], it appears that PuMet may only play a role in a certain
developmental stage or under conditions where it is highly
upregulated.
The targeted deletion of the mouse DNMT gene resulted in
embryonic lethality [12] ; however, undi¡erentiated ES cells
are able to grow. These ES cells retain the ability to methylate
newly integrated retroviruses [13,28]. Thus PuMet may medi-
ate this de novo methylation of retroviral DNA. This could be
tested by generating the targeted deletion of PuMet in
DNMT3=3 ES cells.
4. Note added in proof
While this work was being written, the sequence of PuMet
was published as DNA methyltransferase 2 (DNMT2) by J.A.
Yoder and T.H. Bestor [Hum. Mol. Genet. 7 (1998) 279^284]
(accession number AF012128).
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